These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3312726)

  • 21. [Structure of the dermo-epidemic junction].
    Squiquera L; Robledo MA; Martins CR; Díaz LA
    Med Cutan Ibero Lat Am; 1988; 16(6):474-80. PubMed ID: 3073273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Some biochemical properties of pemphigoid antigen bound to the surface of dissociated epidermal basal cells.
    Grekin PM; Levy GN; King AJ; Diaz LA
    J Invest Dermatol; 1981 Mar; 76(3):190-2. PubMed ID: 7017011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneous distribution of bullous pemphigoid antigen during hair development in the mouse.
    Bard S; Micouin C; Thivolet J; Sengel P
    Arch Anat Microsc Morphol Exp; 1981; 70(2):141-8. PubMed ID: 7034649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of bullous pemphigoid antigen in peritumoral lacunas of basal cell carcinomas.
    Mérot Y; Faucher F; Didierjean L; Saurat JH
    Acta Derm Venereol; 1984; 64(3):209-13. PubMed ID: 6204481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The molecular pathogenesis of bullous pemphigoid.
    Wintroub BU; Wasserman SI
    Clin Dermatol; 1987; 5(1):126-34. PubMed ID: 3552182
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunopathological study of bullous pemphigoid, cicatricial pemphigoid and herpes gestationis].
    Barthélémy H; Ohrt C; Thivolet J
    Ann Dermatol Venereol; 1985; 112(5):403-10. PubMed ID: 3898966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and partial characterization of pemphigoid antigen extracted from normal human skin.
    Stanley JR; Woodley DT; Katz SI
    J Invest Dermatol; 1984 Jan; 82(1):108-11. PubMed ID: 6361166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The significance of antibody determination in the diagnosis of pemphigus and pemphigoid in the oral cavity using the indirect immunofluorescence method].
    Drízhal I; Nozicka Z; Rozsívalová V
    Cesk Stomatol; 1981 Mar; 81(2):94-9. PubMed ID: 7013995
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of animal skin substrates for indirect immunofluorescence diagnosis of subepidermal autoimmune bullous diseases.
    Kanitakis J; Cozzani E; Peyron E; Bourchany D; Claudy A
    Arch Dermatol; 1994 Dec; 130(12):1558. PubMed ID: 7986134
    [No Abstract]   [Full Text] [Related]  

  • 30. Abnormal expression of HLA-DR antigen in the placenta of a patient with pemphigoid gestationis.
    Borthwick GM; Sunderland CA; Holmes RC; Black MM; Stirrat GM
    J Reprod Immunol; 1984 Dec; 6(6):393-6. PubMed ID: 6394752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlation between immunologic reactivity and the clinical development in a case of bullous pemphigoid].
    Renoux M; Paulay AM; Carli-Basset C; Lorette G; Renoux G
    Ann Dermatol Venereol; 1980; 107(11):1095-6. PubMed ID: 7015971
    [No Abstract]   [Full Text] [Related]  

  • 32. Bullous pemphigoid.
    Korman NJ
    Dermatol Clin; 1993 Jul; 11(3):483-98. PubMed ID: 8365034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune complex-mediated complement activation in bullous pemphigoid.
    Gammon WR
    Clin Dermatol; 1987; 5(1):110-6. PubMed ID: 3552180
    [No Abstract]   [Full Text] [Related]  

  • 34. Mixed form of dermatitis herpetiformis and bullous pemphigoid.
    Falk ES; Rekvig OP
    Acta Derm Venereol; 1980; 60(3):229-34. PubMed ID: 6158225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukocyte chemotaxis to the dermal-epidermal junction of human skin mediated by pemphigoid antibody and complement: mechanism of cell attachment in the in vitro leukocyte attachment method.
    Gammon WR; Merritt CC; Lewis DM; Sams WM; Wheeler CE; Carlo J
    J Invest Dermatol; 1981 Jun; 76(6):514-22. PubMed ID: 7017015
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunologic phenomena in the skin of patients with pemphigoid in relation to the pathologic process].
    Torzecka JD; Lutowiecka-Wranicz A; Sysa-Jedrzejowska A; Waszczykowska E; Dziankowska-Bartkowiak B
    Przegl Dermatol; 1988; 75(4):266-71. PubMed ID: 3070636
    [No Abstract]   [Full Text] [Related]  

  • 37. Localized chronic pemphigoid of Brunsting-Perry. Ultrastructural localization of IgG and complement components.
    Murata Y; Tani M; Kumano K
    Arch Dermatol; 1983 Nov; 119(11):921-4. PubMed ID: 6357105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum IgE levels in patients with bullous pemphigoid.
    Nieboer C
    Acta Derm Venereol; 1985; 65(3):273-4. PubMed ID: 2411092
    [No Abstract]   [Full Text] [Related]  

  • 39. Ultrastructural localization of immunoglobulins in the dermo-epidermal junction of patient with bullous pemphigoid.
    Masutani M; Ogawa H; Taneda A; Shoji M; Miyazaki H
    J Dermatol; 1978 Jun; 5(3):107-12. PubMed ID: 353111
    [No Abstract]   [Full Text] [Related]  

  • 40. High histamine level in the blister fluid of bullous pemphigoid.
    Katayama I; Doi T; Nishioka K
    Arch Dermatol Res; 1984; 276(2):126-7. PubMed ID: 6372708
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.